As a pediatric endocrinologist, I care for patients with a broad range of diagnoses impacting the endocrine system (including growth, thyroid, pituitary, pubertal and adrenal disorders, as well as type 1 diabetes), with a particular interest in growth disorders. During my training, I was fortunate to work with experts in the field, gaining experience evaluating and treating less common conditions such as growth hormone resistance (Laron syndrome, STAT5B deficiency), aggrecan deficiency, Temple syndrome, tricho-rhino-pharyngeal syndrome and Silver-Russell syndrome, amongst others. As a member of the Cincinnati Center for Growth Disorders, I hope to continue efforts to meet the needs of patients and families.
I was drawn to pediatric endocrinology by the opportunity to develop long-term relationships with patients and families, the broad clinical scope of diagnosis and the numerous research opportunities.
I believe in a pragmatic approach to work-up and management, working closely with patients and families in shared decision-making that tailors patient care to their needs. I incorporate aspects of evidence-based medicine and cost-conscientious decision-making in my discussions with patients and families.
With my research endeavors, I hope to help uncover new and emerging growth modalities that improve efficacy for known indications, expand treatment availability to broader indications and improve patient experience and quality of care. I additionally have a research interest in diabetes technology, optimizing utilization and better matching capabilities of technology devices with patient care needs in those with diabetes.
In my free time, I enjoy playing tennis, traveling to learn about new cultures and environments, and discovering all the things Cincinnati has to offer.
MD: University of Wisconsin School of Medicine and Public Health, Madison, WI, 2016.
Residency: Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, 2016-2019.
Fellowship: Pediatric Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2019-2022.
Certification: American Board of Pediatrics, 2019; Subspecialty Board of Pediatric Endocrinology, 2023.
Growth disorders; type 1 diabetes; pediatric endocrinology
Endocrinology
Growth disorders; emerging growth modalities
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Recombinant Human Insulin-Like Growth Factor-1 Treatment of Severe Growth Failure in Three Siblings with STAT5B Deficiency. Hormone Research in Paediatrics: from developmental endocrinology to clinical research. 2024; 97:195-202.
Five-Year Therapy with Recombinant Human Insulin-Like Growth Factor-1 in a Patient with PAPP-A2 Deficiency. Hormone Research in Paediatrics: from developmental endocrinology to clinical research. 2023; 96:449-457.
Treatment of Short Stature in Aggrecan-deficient Patients With Recombinant Human Growth Hormone: 1-Year Response. The Journal of Clinical Endocrinology and Metabolism. 2022; 107:e2103-e2109.
Case 2: Chronic Feeding Intolerance in a 9-year-old Boy with a Complex Medical History. Pediatrics in review / American Academy of Pediatrics. 2020; 41:200-202.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey